Oxypro 10mg modified-release tablets
BNF presentation 0407020ADBSABAF within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBSABAF
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
16,733
NHS spend (£)
£89,539.56
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 2,855 |
| February 2025 | 40 |
| December 2024 | 834 |
| November 2024 | 2,983 |
| October 2024 | 2,993 |
| September 2024 | 6 |
| August 2024 | 283 |
| July 2024 | 3,024 |
| May 2024 | 720 |
| July 2021 | 516 |
| June 2021 | 373 |
| December 2020 | 983 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 85 | No data available |
| Unknown pharmacy | 63 | No data available |
| Unknown pharmacy | 58 | No data available |
| Unknown pharmacy | 49 | No data available |
| Unknown pharmacy | 48 | No data available |
| Unknown pharmacy | 48 | No data available |
| Unknown pharmacy | 47 | No data available |
| Unknown pharmacy | 46 | No data available |
| Unknown pharmacy | 45 | No data available |
| Unknown pharmacy | 44 | No data available |